Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBeximco Pharma Regulatory News (BXP)

  • This share is currently suspended. It was suspended at a price of 42.50

Share Price Information for Beximco Pharma (BXP)

Share Price is delayed by 15 minutes
Get Live Data
42.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £189.60m
BXP Live PriceLast checked at - London Stock Exchange

Intraday Beximco Pharma Share Chart

Date   Source Headline
31st Mar 202311:03 amRNSHoldings in Company
30th Jan 20237:00 amRNSHalf Year Results 2022-23
19th Jan 20237:00 amRNSPayment of Cash Dividend
23rd Dec 20227:00 amRNSAnnual General Meeting Statement
29th Nov 20222:06 pmRNSSecond Price Monitoring Extn
29th Nov 20222:00 pmRNSPrice Monitoring Extension
16th Nov 20227:00 amRNSAGM Notification
11th Nov 20227:00 amRNSFinancial Results for the First Quarter
8th Nov 20227:00 amRNSResults for the 12-month period ended 30 June 2022
28th Oct 20227:00 amRNSNotification of Preliminary Results and AGM
28th Apr 20227:00 amRNSQ3 Financial Results
1st Apr 20227:00 amRNSSanofi Bangladesh Ltd. renamed Synovia Pharma PLC
17th Mar 20222:30 pmRNSMPP sub-license for Pfizer’s COVID-19 treatment
28th Jan 20227:00 amRNSHalf Year Results 2021-22
21st Jan 20227:00 amRNSPayment of Cash Dividend
20th Jan 20229:00 amRNSLicense to produce molnupiravir for COVID-19
30th Dec 202110:38 amRNSWorld's first generic version of Pfizer’s Paxlovid
24th Dec 20217:00 amRNSAnnual General Meeting Statement
8th Dec 20217:00 amRNSDelivery of COVID-19 vaccine doses
2nd Dec 20217:00 amRNSUpdate on the supply of COVID-19 vaccine
24th Nov 20217:43 amRNSStatement re: media comment
16th Nov 20217:00 amRNSNotice of AGM
11th Nov 202110:30 amRNSResults for First Quarter Ended 30 September 2021
9th Nov 20217:00 amRNSLaunch of world’s first generic molnupiravir
2nd Nov 20217:00 amRNSResults for the year ended 30 June 2021
21st Oct 202112:36 pmRNSNotification of Preliminary Results and AGM
11th Oct 20217:00 amRNSUpdate on the supply of COVID-19 vaccine
1st Oct 20217:00 amRNSCompletion of Sanofi Bangladesh Acquisition
14th Sep 202110:20 amRNSSanofi Bangladesh Share Purchase Agreement signed
3rd Sep 20211:10 pmRNSAcquisition Approved by Bangladesh Bank
25th Aug 20216:01 pmRNSStatement re: media comment
26th Jul 20217:00 amRNSFDA approval for muscle relaxant drug Baclofen
7th Jul 20212:23 pmRNSUpdate on the supply of COVID-19 vaccine
30th Apr 20217:00 amRNSQ3 Financial Results
28th Apr 20217:00 amRNSUpdate on the supply of COVID-19 vaccine
24th Mar 20214:41 pmRNSSecond Price Monitoring Extn
24th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20212:06 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
24th Mar 202111:06 amRNSSecond Price Monitoring Extn
24th Mar 202111:00 amRNSPrice Monitoring Extension
4th Feb 20217:34 amRNSUpdate on the supply of COVID-19 vaccine
28th Jan 20217:00 amRNSHalf Year Results 2020-21
22nd Jan 20217:00 amRNSPayment of Cash Dividend
21st Jan 20219:34 amRNSProposed acquisition of stake in Sanofi Bangladesh
18th Jan 20217:00 amRNSBoard Changes
14th Jan 20219:00 amRNSUpdate on the supply of COVID-19 vaccine
11th Jan 20217:00 amRNSStock Dividend Issued
11th Jan 20217:00 amRNSConfirmation of Board Changes
21st Dec 20207:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.